ALLO-647
ALLO-647 is a human monoclonal antibody targeting CD52. ALLO-647 transiently and selectively depletes host lymphocytes to promote the proliferation of allogeneic CAR T-cell following infusion. ALLO-647 can be used for the research of B-cell lymphoma and follicular lymphoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Human
ALLO-647 is a human monoclonal antibody targeting CD52, a GPI-anchored low-molecular-weight glycoprotein that is highly expressed on almost all mature T and B cells but not on hematopoietic stem cells. Soluble CD52 is a natural inhibitor of the NF‑κB pathway, which mainly functions in myeloid cells and also exerts cross-regulation in T/B cells.[1]
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
CD52
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)